161 related articles for article (PubMed ID: 28235211)
21. An emerging problem: methamphetamine abuse among treatment seeking youth.
Gonzales R; Ang A; McCann MJ; Rawson RA
Subst Abus; 2008; 29(2):71-80. PubMed ID: 19042326
[TBL] [Abstract][Full Text] [Related]
22. The epidemiology of methamphetamine use and harm in Australia.
Degenhardt L; Roxburgh A; Black E; Bruno R; Campbell G; Kinner S; Fetherston J
Drug Alcohol Rev; 2008 May; 27(3):243-52. PubMed ID: 18368605
[TBL] [Abstract][Full Text] [Related]
23. Treatment outcomes for methamphetamine users receiving outpatient counselling from the Stimulant Treatment Program in Australia.
McKetin R; Dunlop AJ; Holland RM; Sutherland RA; Baker AL; Salmon AM; Hudson SL
Drug Alcohol Rev; 2013 Jan; 32(1):80-7. PubMed ID: 22642414
[TBL] [Abstract][Full Text] [Related]
24. [In Germany difficult to come by. Crystal meth: "definitely one of the most dangerous drugs in the world"].
Oberhofer E
MMW Fortschr Med; 2014 Aug; 156(14):18-9. PubMed ID: 25195388
[No Abstract] [Full Text] [Related]
25. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence.
Johnson BA; Ait-Daoud N; Elkashef AM; Smith EV; Kahn R; Vocci F; Li SH; Bloch DA;
Int J Neuropsychopharmacol; 2008 Feb; 11(1):1-14. PubMed ID: 17470315
[TBL] [Abstract][Full Text] [Related]
26. Crystal methamphetamine use associated with non-fatal overdose among a cohort of injection drug users in Vancouver.
Fairbairn N; Wood E; Stoltz JA; Li K; Montaner J; Kerr T
Public Health; 2008 Jan; 122(1):70-8. PubMed ID: 17645904
[TBL] [Abstract][Full Text] [Related]
27. Women with methamphetamine dependence: research on etiology and treatment.
Cohen JB; Greenberg R; Uri J; Halpin M; Zweben JE
J Psychoactive Drugs; 2007 Nov; Suppl 4():347-51. PubMed ID: 18284101
[TBL] [Abstract][Full Text] [Related]
28. The Consumption of New Psychoactive Substances and Methamphetamine.
de Matos EG; Hannemann TV; Atzendorf J; Kraus L; Piontek D
Dtsch Arztebl Int; 2018 Jan; 115(4):49-55. PubMed ID: 29467073
[TBL] [Abstract][Full Text] [Related]
29. Impaired physical health among methamphetamine users in comparison with the general population: the role of methamphetamine dependence and opioid use.
McKetin R; Kelly E; McLaren J; Proudfoot H
Drug Alcohol Rev; 2008 Sep; 27(5):482-9. PubMed ID: 18608459
[TBL] [Abstract][Full Text] [Related]
30. [Bio-Psycho-Social Characteristics and Therapeutic Aspects of Methamphetamine-Dependent Women - Gender Specific Results of a Systematic Literature Search].
Neumann S; Soyka M; Franke AG
Psychother Psychosom Med Psychol; 2018 Jul; 68(7):281-289. PubMed ID: 28838011
[TBL] [Abstract][Full Text] [Related]
31. Treatment of methamphetamine use disorders: an update.
Rawson RA; Gonzales R; Brethen P
J Subst Abuse Treat; 2002 Sep; 23(2):145-50. PubMed ID: 12220612
[TBL] [Abstract][Full Text] [Related]
32. An exploration of self-perceived non-problematic use as a barrier to professional support for methamphetamine users.
Quinn B; Stoové M; Papanastasiou C; Dietze P
Int J Drug Policy; 2013 Nov; 24(6):619-23. PubMed ID: 23867050
[No Abstract] [Full Text] [Related]
33. The methamphetamine epidemic and dentistry.
Klasser GD; Epstein JB
Gen Dent; 2006; 54(6):431-9; quiz 440, 448. PubMed ID: 17134084
[TBL] [Abstract][Full Text] [Related]
34. A Review of Methamphetamine Dependence and Withdrawal Treatment: A Focus on Anxiety Outcomes.
Hellem TL
J Subst Abuse Treat; 2016 Dec; 71():16-22. PubMed ID: 27776672
[TBL] [Abstract][Full Text] [Related]
35. Methamphetamine use among Australian workers and its implications for prevention.
Roche AM; Pidd K; Bywood P; Freeman T
Drug Alcohol Rev; 2008 May; 27(3):334-41. PubMed ID: 18368616
[TBL] [Abstract][Full Text] [Related]
36. Pharmacotherapeutic agents in the treatment of methamphetamine dependence.
Morley KC; Cornish JL; Faingold A; Wood K; Haber PS
Expert Opin Investig Drugs; 2017 May; 26(5):563-578. PubMed ID: 28351169
[TBL] [Abstract][Full Text] [Related]
37. Congressional staff are briefed on methamphetamine.
Roehr B
BMJ; 2007 Sep; 335(7619):535. PubMed ID: 17855307
[No Abstract] [Full Text] [Related]
38. A nine session manual of motivational enhancement therapy for methamphetamine dependence: adherence and efficacy.
Galloway GP; Polcin D; Kielstein A; Brown M; Mendelson J
J Psychoactive Drugs; 2007 Nov; Suppl 4():393-400. PubMed ID: 18286727
[TBL] [Abstract][Full Text] [Related]
39. Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men.
Shoptaw S; Reback CJ; Peck JA; Yang X; Rotheram-Fuller E; Larkins S; Veniegas RC; Freese TE; Hucks-Ortiz C
Drug Alcohol Depend; 2005 May; 78(2):125-34. PubMed ID: 15845315
[TBL] [Abstract][Full Text] [Related]
40. Methamphetamine-Associated Congestive Heart Failure: Increasing Prevalence and Relationship of Clinical Outcomes to Continued Use or Abstinence.
Sliman S; Waalen J; Shaw D
Cardiovasc Toxicol; 2016 Oct; 16(4):381-9. PubMed ID: 26661075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
